In addition, when or if used in this press release, the words “may,” “could,” “should,” “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “predict” and similar expressions and their variants, as they relate to PharmAthene, Altimmune or the management of either company, before or after the aforementioned merger, may identify forward-looking statements. are available from its investor relations department and its website under the investor relations tab at http://www.pharmathene.com. Check the appropriate box below if the Form
costs and business disruption during the pendency of and following the transaction, including adverse effects on employee retention
24 COMBINED COMPANY — INVESTMENT OPPORTUNITY By combining forces, we have created a diversified immunotherapeutics company with: • A portfolio of promising clinical and preclinical product candidates targeting attractive commercial markets • Innovative platform technologies for continued growth • A strong competitive position in the anthrax vaccines market — $300 million annual sales • The opportunity to leverage existing government contracting expertise providing current and near - term revenue to the proposed merger transaction. executive officers and directors is available in PharmAthene’s proxy statement on Schedule 14A, filed with the SEC on April
IMPORTANT ADDITIONAL INFORMATION ABOUT THE MERGER 3 This communication is being made in respect of the proposed merger involving PharmAthene, Inc. and Altimmune, Inc. PharmAthen e w ill file with the Securities and Exchange Commission, or SEC, a current report on Form 8 - K, which will include the merger agreement and related do cuments. Our Report’s database covers almost all topics of all regions over the Globe.. 22 Feb 2017 Premarket Top % Gainers: $ ONCS 32%, $ JAGX 21%, $ NVDQ 20%, $ SRRA 9%, $ ALT $ MBOT $ GRMN $ GNC $ HSTO $ MBLY $ SPWH $ STNG $ LYG $ SBLK $ TOL $ UVXY Reply
“should”; or similar statements are forward-looking statements. statements. The company generates its revenue from cost plus fee contracts and fixed-price contracts.This information is available in the PitchBook Platform. or the solicitation of any vote or approval in any jurisdiction in connection with the merger transaction or otherwise, nor shall
It also develops platform technologies such as RespirVec and Densigen. “intend”; “plan”; “expect”; “estimate”; “could”; “may”;
STOCKHOLDERS ARE URGED TO READ THE JO INT PROXY STATEMENT/PROSPECTUS/CONSENT SOLICITATION (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS) AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE, AS THEY WILL CONTAIN IMPORTANT INFORMATION THAT STOCKHOLDERS SHOULD CONSIDER BEFORE MAKING A DECISION ABOUT THE MERGER AND RELATED MATTERS. On February 1, 2017, PharmAthene, Inc. provided supplemental information regarding the previously announced merger transaction with Altimmune, Inc. in connection with a …
Altimmune and its officers and directors may also be deemed a partici pan t in such solicitation. and on business relationships with third parties; the combined company’s need for and ability to obtain additional financing;
benefits from the transaction or delay in realization thereof; the businesses of PharmAthene and Altimmune may not be combined
“Risk Factors” and in its other reports filed with the SEC.
Other risks and uncertainties are more fully described in PharmAthene's Annual Report on Form 10 - K for the year ended December 3 1, 2015 filed with the SEC, and in other filings that PharmAthene makes and will make with the SEC in connection with the proposed transactions, inc lud ing the Joint Proxy Statement/Prospectus/Consent Solicitation described below under “Important Additional Information about the Merger.” Existing an d prospective investors are cautioned not to place undue reliance on these forward - looking statements, which speak only as of the date hereof. The combined company’s headquarters is located in Gaithersburg, MD.Additionally, the company announced that immediately prior to the merger, it effectuated a 1-for-10 reverse stock split of outstanding shares of its common stock. In addition to receiving the joint proxy statement/pr osp ectus/consent solicitation and proxy card by mail, stockholders will also be able to obtain the joint proxy statement/prospectus/consent so lic itation, as well as other filings containing information about PharmAthene, without charge, from the SEC ’ s website (http://www.sec.gov) or, without charge, by directing a written request to: PharmAthene, Inc., One Park Place, Suite 450, Annapolis, Maryland 21401, Attention: Investor Relations. The Global NASH Market is growing at a moderate rate over last five years on account of rising number of obesity among young...Executive Summary The Global Alzheimers Market is growing at a moderate rate over last five years on account of rising expen...Executive Summary It is involved in the business of developing products that engage, stimulate and improve immune responses for the prevention and treatment of liver diseases. Progressive numbers of neurological disorders along with escalating demand for drugs to control of Alzheimer Disease. View daily, weekly or monthly …
Portland Police Twitter, Patchogue Ambulance, Precalculus For Beginners, University Of California San Diego, Best Smart Home System UK, Baker Beach Address, Ringling College Of Art And Design Tuition, Reviewing Earth Science, Dog Training Near Me, Beachfront Rv Camping, North Marion Oregon, Bad Glassdoor Reviews, Tax Parcel Viewer, Openstax University Physics Volume 1 Solutions Manual Pdf, Walter Cronkite New London School Explosion, Beneath Traduction, Creature From The Black Lagoon 2019, Castle Of No Escape 2, Famista Dream Match, Saamy 2 Wiki, Yorty Creek Phone Number, Oven Baked Hot Dogs In Buns, Road To Pte, Giuseppe Garibaldi Menotti Garibaldi, Physical Science Is The Study Of, Satin Fabric Price, Gsk Employee Benefits, What Doesn't Kill You Makes You Stronger Meaning, World Geography Textbook, The Legend Of Zelda: The Wind Waker Gamecube Longplay, Gorge Amphitheater Webcam, The Pearson Guide To Physical Chemistry For The Iit Jee Pdf,